Skip to main content

Double-Bundle Anterior Cruciate Ligament Reconstruction Provides Superior Short-to-Midterm Rotational Stability But Not Clinically Important Functional Gains Over Single-Bundle: A Systematic Review and Meta-analysis

In brief

Double-bundle ACL reconstruction reduces pivot-shift findings by 40% at 2 to 4 years

In 13 randomized trials involving 1,041 patients, double-bundle reconstruction reduced positive pivot-shift findings by 40% at 2 to 4 years, with 10 patients needing the procedure to prevent one positive test. Patient-reported scores were statistically higher but fell short of clinically important gains, and no clear differences persisted beyond 4 years; study differences limit certainty about which patients benefit.

Journal
Arthroscopy, sports medicine, and rehabilitation (Q1)
Published
16 October 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Manuel Alberto Gutierrez-Moreno, Luis Eduardo Arámbula-Torres, Ramon Alonso Prieto-Baeza, Carlos Leal-Contreras, Cristina Alejandra Fuentes-Flores, Edmundo Berumen-Nafarrate
PMID
42890719
DOI
10.1002/ars2.70102

Why clinicians should know about it

Abstract

PURPOSE: To compare the biomechanical and functional outcomes between single-bundle and double-bundle (DB) anterior cruciate ligament reconstruction techniques using the most current evidence, stratified by follow-up duration. METHODS: PubMed, Embase, and Cochrane databases were searched from 2013 to September 2025 for randomized controlled trials comparing single-bundle versus DB anterior cruciate ligament reconstruction with a minimum follow-up of 24 months. Primary outcomes included anterior tibial translation, rotational stability (pivot shift), and patient-reported outcomes (subjective International Knee Documentation Committee, Lysholm score). Secondary outcomes included return-to-sport and graft failure rate. Continuous outcomes were pooled using inverse-variance random-effects models (DerSimonian-Laird) and dichotomous outcomes using Mantel-Haenszel fixed-effect models, with stratification by follow-up duration (24-48 months vs >48 months). Heterogeneity was assessed using the I 2 statistic. RESULTS: Thirteen randomized controlled trials (1041 patients; 536 single-bundle, 505 DB; mean age 30.2 years; 68% men; follow-up 24-122 months) were included. At 24 to 48 months, DB reconstruction significantly reduced the risk of a positive pivot shift (risk ratio 0.60, 95% confidence interval [CI] 0.43-0.84, P = .003; number needed to treat = 10) and showed statistically higher subjective International Knee Documentation Committee (mean difference 5.88 points, 95% CI 0.44-11.33) and Lysholm (mean difference 7.47 points, 95% CI 0.06-14.88) scores; however, neither reached established minimal clinically important difference thresholds (11.5 and 8.9 points, respectively). Anterior tibial translation did not differ significantly between techniques (mean difference -0.34 mm, 95% CI -1.04 to 0.35, P = .327). No study reported sex-disaggregated outcomes or individual-level minimal clinically important difference attainment. Beyond 48 months, no significant differences were observed for any outcome. CONCLUSIONS: DB reconstruction shows statistically significant improvements in rotational stability and patient-reported functional scores at 24 to 48 months, but functional differences do not reach established minimal clinically important difference thresholds. No significant differences were observed beyond 48 months, a finding likely influenced by substantial study heterogeneity and graft selection. The current evidence does not support a universal clinical advantage for the DB technique; shared decision-making based on patient activity demands and surgeon experience remains essential. LEVEL OF EVIDENCE: Level I, systematic review and meta-analysis of randomized controlled trials.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.